• share
• favorite_border

Fred Hutchinson Cancer Research Center, a world leader in lifesaving research to prevent, detect and treat cancer, HIV/AIDS and other deadly diseases, announced today that it has named an internationally renowned expert in cancer genetics and precision medicine as its new president and director. D. Gary Gilliland, M.D., Ph.D., a physician-scientist with a background in academic medicine and the pharmaceutical industry, will take the helm as Fred Hutch’s new leader on Jan. 2.

• share
• favorite_border

A potentially groundbreaking study by Fred Hutchinson Cancer Research Center scientists, published online today in the journal PLOS ONE, suggests that the worst effects of reperfusion injury may be prevented with a safe, simple solution: a dose of iodide, a chemical form of the element added to ordinary table salt.

• share
• favorite_border

Living healthy is hard. Most people who try to change habits, such as smoking, will lapse. But science is giving new hope. Dr. Jonathan Bricker is an internationally recognized scientific leader in a bold approach called acceptance and commitment therapy. A Stanford researcher called his use of the approach “a breakthrough in behavioral research [that] has major public health implications for the major causes of preventable death.”

• share
• favorite_border

• share
• favorite_border

Fred Hutchinson Cancer Research Center employees will join in Seattle’s PrideFest 2014 parade in support of the diversity and ongoing accomplishments of the area’s LGBT community

• share
• favorite_border

Economic findings on the Women’s Health Initiative estrogen plus progestin trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published.

• share
• favorite_border

Fred Hutchinson Cancer Research Center scientists striving for new cancer cures — and the patients who stand to benefit from them — got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch’s history.

• share
• favorite_border

The time is right – you’re ready to quit smoking. Begin with just a click at WebQuit.org. WebQuit is an online quit-smoking program and research study being conducted by researchers at Fred Hutchinson Cancer Research Center. The WebQuit study, which is funded by the National Cancer Institute, is testing two online quit-smoking programs to learn which one is most useful to help people quit.

• share
• favorite_border

HIV expert Dr. Glenda Gray, co-principal investigator of the HIV Vaccine Trials Network (HVTN), which is headquartered at Fred Hutchinson Cancer Research Center, has been named president of the South African Medical Research Council, the premier medical research organization and funder of medical research in South Africa. The appointment is effective April 1.

• share
• favorite_border

Thirteen graduate students from institutes throughout North America have been chosen to receive the 2014 Harold M. Weintraub Graduate Student Award sponsored by the Basic Sciences Division of Fred Hutchinson Cancer Research Center. Nominations were solicited internationally; the winners were selected on the basis of the quality, originality and significance of their work.

• share
• favorite_border

A simple questionnaire that rates breathing difficulties on a scale of 0 to 3 predicts survival in chronic graft-vs.-host disease, according to a study published in the March issue of Biology of Blood and Marrow Transplantation.

• share
• favorite_border

Researchers at Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) were recognized in several categories of Seattle Business Magazine’s 2014 Leaders in Health Care Awards, including the publication’s Lifetime Achievement Award, given to Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutch and president of SCCA.

• share
• favorite_border

A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man’s selenium status before taking the supplements.

• share
• favorite_border

Pancreas cancer is notoriously impervious to treatment and resists both chemotherapy and radiotherapy. It has also been thought to provide few targets for immune cells, allowing tumors to grow unchecked. But new research from Fred Hutchinson Cancer Research Center shows that pancreas cancer “veils” itself from the immune system by recruiting specialized immune suppressor cells. The research team also found that removing these cells quickly triggers a spontaneous anti-tumor immune response.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

New drug, idelalisib, shows efficacy in treating patients with relapsed indolent non-Hodgkin lymphom

• share
• favorite_border

Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence. Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood of prostate cancer overdiagnosis. They announced their findings this week in the online issue of the Journal of the National Cancer Institute.

• share
• favorite_border

• share
• favorite_border

The Hutchinson Institute for Cancer Outcomes Research (HICOR), an innovative research institute based at Fred Hutchinson Cancer Research Center that is charged with evaluating and improving the effectiveness and value of cancer prevention and treatment strategies through collaborative research – including health-economic analyses – has hired Gary Lyman, M.D., M.P.H., of Duke University to serve as the Institute’s co-director. His official start date was Jan. 2.

• share
• favorite_border

“Quingo,” a game launched in September by local startup Game It Forward for the iPhone, iPad and iPod Touch, today, just in time for the holidays, released a new “Winter Wonderland” question pack. For $3.99, players can receive 50 holiday and winter-themed questions.Six Seattle-based charities receive funds from the game, which combines the fun of bingo with the challenge of trivia questions.

• share
• favorite_border

New study affirms the use of large-scale protein measurements to validate disease biomarkers and drug targets

• share
• favorite_border

Scientists develop new method for counting cancer-fighting cells in ovarian cancer patients

• share
• favorite_border

Fred Hutch researchers discover that cancer develops a few years after cells undergo drastic mutations, contrary to common belief.

• share
• favorite_border

A team of scientists looking into the interplay of the immune system and cancer have found a link between a history of airborne allergies – in particular to plants, grass and trees – with risk of blood cancers in women.

• share
• favorite_border

Seattle Mariners player Raúl Ibañez named Hutch Award® winner.

• share
• favorite_border

A Fred Hutchinson Cancer Research Center-led study has found that two organochlorine pesticides are associated with an increased risk of endometriosis, a condition that affects up to 10 percent of reproductive-age women.

• share
• favorite_border

“Quingo,” a game created by local startup Game It Forward that was first released in September for the iPad, will be available for the iPhone starting Oct. 31. Six charities, including five based in Seattle, receive funds from the game, which combines the fun of bingo with the challenge of trivia questions.

• share
• favorite_border

Fred Hutchinson Cancer Research Center tomorrow will celebrate the grand opening of a state-of-the-art HIV vaccine laboratory in Cape Town, South Africa. The lab will be one of Africa’s most advanced scientific facilities.

• share
• favorite_border

Frederick R. Appelbaum, M.D., executive vice president and deputy director of Fred Hutchinson Cancer Research Center, has been elected to the Institute of Medicine. Election to IOM is considered to be one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to science.